Ray P, Antoine M, Mary-Krause M, Lebrette M G, Wislez M, Duvivier C, Meyohas M C, Girard P M, Mayaud C, Cadranel J
Services de Pneumologie et de Réanimation Respiratoire et Service d'Anatomie-Pathologique, Hôpital Tenon, 4 rue de la Chine, 75020 Paris, France.
Am J Respir Crit Care Med. 1998 Oct;158(4):1221-9. doi: 10.1164/ajrccm.158.4.9801057.
We describe 12 cases of AIDS-related primary pulmonary lymphoma occurring between 1986 and 1996 in a large French cohort of HIV-infected patients. Diagnostic criteria were: (1) histologically proven lymphomatous pulmonary involvement; (2) absence of mediastinal and/or hilar adenopathy on chest radiography; (3) absence of extrathoracic lymphoma extension. All patients were severely immunodeficient at the time of diagnosis. All but one patient presented with B and/or nonspecific respiratory symptoms. Chest radiography showed one or more marginated nodule(s) or large mass. CT scan showed a cavitary lesion in five patients. No lymph node enlargement or specific pleural effusion was detected. Transthoracic needle biopsies were performed in 10 patients and avoided open-lung biopsy for the diagnosis of lymphoma in five patients. All but one of the primary pulmonary lymphoma were high-grade B-cell non-Hodgkin's lymphomas. Using antilatent membrane protein-1 antibodies and an Epstein-Barr-Virus-encoded RNA transcript-specific probe, latent EBV infection of tumor cells was demonstrated in every case. All but one of the patients received chemotherapy. The median survival time was 4 mo, and no patient was still alive at the cut-off date for this analysis. Progessive pulmonary lymphoma was the main cause of death, but infections were also frequent.
我们描述了1986年至1996年间在一个大型法国HIV感染患者队列中发生的12例艾滋病相关原发性肺淋巴瘤病例。诊断标准为:(1)组织学证实有淋巴瘤性肺受累;(2)胸部X线检查无纵隔和/或肺门淋巴结肿大;(3)无胸外淋巴瘤扩散。所有患者在诊断时均严重免疫缺陷。除1例患者外,所有患者均有B和/或非特异性呼吸道症状。胸部X线检查显示一个或多个边缘清晰的结节或大肿块。CT扫描显示5例患者有空洞性病变。未检测到淋巴结肿大或特异性胸腔积液。10例患者进行了经胸针吸活检,5例患者避免了开胸肺活检以诊断淋巴瘤。除1例原发性肺淋巴瘤外,其余均为高级别B细胞非霍奇金淋巴瘤。使用抗潜伏膜蛋白-1抗体和爱泼斯坦-巴尔病毒编码的RNA转录物特异性探针,在每例病例中均证实肿瘤细胞存在潜伏性EBV感染。除1例患者外,所有患者均接受了化疗。中位生存时间为4个月,在本次分析的截止日期时无患者存活。进行性肺淋巴瘤是主要死因,但感染也很常见。